Target intelligence / Profile preview

Influenza B Virus Hemagglutinin (Yamagata Lineage) (HA)

Target
HA
Molecular classification
Viral protein, Glycoprotein, Class I fusion protein
01

Overview

Influenza B virus hemagglutinin from the Yamagata lineage is an essential class I fusion protein responsible for binding sialic acid receptors on human respiratory epithelial cells and facilitating entry through membrane fusion. Its structure—a trimer with variable head domains—determines both its antigenicity and receptor specificity. Differences between lineages/subtypes affect immune recognition but core functions remain highly conserved across all influenza HAs. This protein remains central to diagnostics and vaccine design against seasonal flu caused by type B viruses.

Other names
HemagglutininInfluenza B HAYamagata HAB/Yamagata lineage hemagglutinin
02

Mechanism of action

Targeted by neutralizing antibodies that block receptor binding or fusion. NA inhibitors prevent release of new virions, thus indirectly limiting HA's spread.

03

Biological functions

Viral attachmentMembrane fusionReceptor bindingAntigen presentationImmune response elicitation
04

Disease associations

InfectionInfluenzaRespiratory disease
05

Safety considerations

Antigenic drift leading to vaccine mismatchPotential for antibody-dependent enhancement (ADE) in some contexts
06

Interacting drugs

Monoclonal antibodies (experimental)

1 more in the full profile.

07

Biomarkers

Antibody titers against HA (for vaccine efficacy)HA sequence variants (for strain identification and vaccine matching)

Beyond the preview

Go deeper on Influenza B Virus Hemagglutinin (Yamagata Lineage) (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza B Virus Hemagglutinin (Yamagata Lineage) (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call